Arcutis Biotherapeutics, Inc. ARQT Finished goods
Finished goods at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryFinishedGoodsNetOfReserves.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s finished goods.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s finished goods?
- Arcutis Biotherapeutics, Inc. (ARQT) reported finished goods of $14.68M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s finished goods changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s finished goods increased by 77.5% year-over-year, from $8.27M to $14.68M.
- What does finished goods mean?
- Completed products ready for sale, valued at the lower of cost or net realizable value.